Please use this identifier to cite or link to this item: https://doi.org/10.1002/ana.21405
Title: Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Authors: Ross, O.A.
Wu, Y.-R.
Lee, M.-C.
Funayama, M.
Chen, M.-L.
Soto, A.I.
Mata, I.F.
Lee-Chen, G.-J.
Chiung, M.C.
Tang, M.
Zhao, Y.
Hattori, N.
Farrer, M.J.
Tan, E.-K. 
Wu, R.-M.
Issue Date: Jul-2008
Citation: Ross, O.A., Wu, Y.-R., Lee, M.-C., Funayama, M., Chen, M.-L., Soto, A.I., Mata, I.F., Lee-Chen, G.-J., Chiung, M.C., Tang, M., Zhao, Y., Hattori, N., Farrer, M.J., Tan, E.-K., Wu, R.-M. (2008-07). Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Annals of Neurology 64 (1) : 88-92. ScholarBank@NUS Repository. https://doi.org/10.1002/ana.21405
Abstract: Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease. © 2008 American Neurological Association. Published by Wiley-Liss, Inc., through Wiley Subscription Services.
Source Title: Annals of Neurology
URI: http://scholarbank.nus.edu.sg/handle/10635/109929
ISSN: 03645134
DOI: 10.1002/ana.21405
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

129
checked on Jul 13, 2018

WEB OF SCIENCETM
Citations

120
checked on Jun 11, 2018

Page view(s)

23
checked on Apr 20, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.